Center Laboratories (4123) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.002x

Based on the latest financial reports, Center Laboratories (4123) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$46.61 Million ≈ $1.47 Million USD) by net assets (NT$19.64 Billion ≈ $618.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 4123 net asset quality index to measure how much of total assets are equity-financed.

Center Laboratories - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Center Laboratories's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Center Laboratories cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Center Laboratories Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Center Laboratories ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Wanbangde Pharmaceutical Holding Group Co Ltd SHE:002082	0.000x
Create Technology & Science Co Ltd SHE:000551	0.010x
Bafang Electric Suzhou Co Ltd SHG:603489	0.017x
Ningbo Menovo Pharm Co Ltd SHG:603538	0.016x
Power Mech Projects Limited NSE:POWERMECH	0.087x
UNITIL Corporation NYSE:UTL	0.026x
Shenzhen Tatfook Tech SHE:300134	-0.004x
Omnia Holdings Limited JSE:OMN	0.071x

Annual Cash Flow Conversion Efficiency for Center Laboratories (2006–2024)

The table below shows the annual cash flow conversion efficiency of Center Laboratories from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see 4123 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$18.05 Billion ≈ $568.82 Million	NT$415.71 Million ≈ $13.10 Million	0.023x	+148.32%
2023-12-31	NT$20.22 Billion ≈ $636.92 Million	NT$-963.44 Million ≈ $-30.35 Million	-0.048x	-383.21%
2022-12-31	NT$19.25 Billion ≈ $606.55 Million	NT$-189.88 Million ≈ $-5.98 Million	-0.010x	+41.91%
2021-12-31	NT$21.09 Billion ≈ $664.61 Million	NT$-358.14 Million ≈ $-11.28 Million	-0.017x	-29.96%
2020-12-31	NT$20.63 Billion ≈ $650.10 Million	NT$-269.56 Million ≈ $-8.49 Million	-0.013x	+29.50%
2019-12-31	NT$15.46 Billion ≈ $487.02 Million	NT$-286.45 Million ≈ $-9.02 Million	-0.019x	-146.39%
2018-12-31	NT$15.47 Billion ≈ $487.30 Million	NT$617.84 Million ≈ $19.47 Million	0.040x	-66.54%
2017-12-31	NT$16.87 Billion ≈ $531.48 Million	NT$2.01 Billion ≈ $63.44 Million	0.119x	+63.44%
2016-12-31	NT$15.82 Billion ≈ $498.51 Million	NT$1.16 Billion ≈ $36.41 Million	0.073x	+886.07%
2015-12-31	NT$14.88 Billion ≈ $468.92 Million	NT$-138.29 Million ≈ $-4.36 Million	-0.009x	-754.87%
2014-12-31	NT$6.94 Billion ≈ $218.54 Million	NT$-7.54 Million ≈ $-237.52K	-0.001x	-113.13%
2013-12-31	NT$5.01 Billion ≈ $157.93 Million	NT$41.50 Million ≈ $1.31 Million	0.008x	+77.01%
2012-12-31	NT$3.47 Billion ≈ $109.32 Million	NT$16.23 Million ≈ $511.33K	0.005x	-85.23%
2011-12-31	NT$2.21 Billion ≈ $69.75 Million	NT$70.11 Million ≈ $2.21 Million	0.032x	+1890.25%
2010-12-31	NT$2.18 Billion ≈ $68.76 Million	NT$-3.86 Million ≈ $-121.64K	-0.002x	-109.56%
2009-12-31	NT$2.11 Billion ≈ $66.57 Million	NT$39.11 Million ≈ $1.23 Million	0.019x	-76.35%
2008-12-31	NT$573.09 Million ≈ $18.06 Million	NT$44.86 Million ≈ $1.41 Million	0.078x	-45.54%
2007-12-31	NT$471.17 Million ≈ $14.84 Million	NT$67.71 Million ≈ $2.13 Million	0.144x	+1.12%
2006-12-31	NT$273.07 Million ≈ $8.60 Million	NT$38.81 Million ≈ $1.22 Million	0.142x	--

About Center Laboratories

TWO:4123 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$877.67 Million

NT$27.86 Billion TWD

Market Cap Rank

#9311 Global

#297 in Taiwan

Share Price

NT$37.75

Change (1 day)

+0.80%

52-Week Range

NT$33.60 - NT$49.35

All Time High

NT$236.72